Subscribe to our Newsletters !!
Although copying the blueprint is extremely comple
Biotech Fluidics offers a range of micro spargers
The recent rabies death of an 11 year old Canadian
Eppendorf is launching the new Centrifuge 5811 R,a
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Micr
Russia expects to register a second possible vaccine against COVID-19 from October 15, the TASS news agency mentioned Russian consumer security watchdog Rospotrebnadzor as saying on Tuesday.
The vaccine was developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.
Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August. Late-stage trials, involving at least 40,000 people, are continuing.
